Htg Molecular Diagnostics, Inc
HTGMQ
Revenue
1.03M
▼-1.41M▼-57.67%
3 Months ChangeAssets
10.87M
▼-6.91M▼-38.88%
3 Months ChangeLiabilities
10.39M
▼-1.99M▼-16.11%
3 Months ChangeFree Cash Flow
-4.37M
▲1.58M▲26.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-06-08
Form 8-K
ID: 0000950170-23-027044
2023-06-05
Form 8-K
ID: 0000950170-23-026337
2023-05-24
Form 8-K
ID: 0000950170-23-023963
2023-05-16
Form 8-K
ID: 0000950170-23-022358
2023-05-11
Form 10-Q
ID: 0000950170-23-020725
2023-05-10
Form 8-K
ID: 0000950170-23-020671
2023-04-25
Form 8-K
ID: 0000950170-23-014248
2023-02-03
Form 8-K
ID: 0000950170-23-001781
2023-01-06
Form 8-K
ID: 0000950170-23-000286
2022-12-29
Form 8-K
ID: 0000950170-22-027080